As set forth in the IPEC-Americas bylaws, IPEC-Americas Executive Committee, (whose members are elected by the Board of Trustees) is empowered to manage the affairs of the Council and its members and to direct the activities of standing committees and working groups. The Executive Committee is comprised of thirteen members who are elected to two or three year terms on a rotating basis depending on their office.
Leadership Team
|
Chair
2026 / 2027
|
Gina Marsee
Director, Compendial Compliance & Advocacy
Merck & Co.
|
Gina Marsee is the Director, Compendial Compliance and Advocacy at Merck located in West Point, PA, USA. Throughout her 30+ year career, Gina has held various leadership roles within Quality, Compliance, and Regulatory Affairs at organizations including ThermoFisher and Pfizer. Gina holds a bachelor’s degree in Chemistry & Biology from the University of Tennessee. She participates with various industry groups, pharmacopoeia organizations, and regulators on contemporary compendial related matters. In addition, Gina advocates for harmonization/convergence of public standard in support of availability of quality medicines for patients globally.
|
|
Immediate Past Chair
2026 / 2027
|
Joseph Zeleznik
Technical Director, North America
IMCD US Pharma
|
Joseph Zeleznik is the Technical Director, North America for IMCD US Pharma where he is responsible for product and technology training, customer seminars, and advising on formulation development through excipient and process selection. He has held roles at MEGGLE USA, Inc., JRS PHARMA and Penwest Pharmaceuticals Co. With nearly 30 years in the pharmaceutical industry, Joe specializes in the development and application of high functionality excipients, focusing on co-processed and other novel excipients. Joe holds B.S. and M.A. degrees in Chemistry from the State University of New York, College at New Paltz. He has authored numerous industry articles and contributed to the Handbook of Pharmaceutical Excipients as well as several IPEC Guides.
|
|
Chair Elect
2026 / 2027
|
Bob Sulouff
Sr. Manager Regulatory Affairs, Health Pharma Solutions BG
Roquette
|
Bob Sulouff has over 25 years’ experience in Regulatory Affairs and Quality, primarily focused on excipients. He is a member of Roquette’s Health and Pharma Solutions Regulatory team, where he advocates for value added pharma regulatory solutions. He previously held positions at Ashland Specialty Ingredients’ Pharmaceutical and Nutrition Business in Regulatory for excipients and food additives and at Bioventus in Quality and Regulatory for HCT/Ps and medical devices. Bob is currently Chair of the IPEC-Americas Regulatory Affairs Committee. |
Vice Chairs and Officers
|
Vice Chair for Administrative Affairs
2026 / 2027 / 2028 |
Douglas Muse
Advisor, External Engagement & Advocacy, Eli Lilly & Co. |
|
Vice Chair for Harmonization and Compendial Monograph
2026 / 2027 / 2028 |
Janeen Skutnik-Wilkinson
Sr. Director, GPO Regulatory Intelligence & Advocacy Global Quality Compliance External Engagement and Advocacy (EEA), Eli Lilly & Co.
|
|
Vice Chair for Maker and Distributor Relations
2024 / 2025 / 2026 |
Charlotte McIlvaine
Manager - North America Pharma Quality, Univar Solutions |
|
Vice Chair for Membership
2024 / 2025 / 2026 |
George Collins
Vice President, Vanderbilt Minerals LLC |
|
Vice Chair for Science and Regulatory Policy
2025 / 2026 / 2027 |
Priscilla Zawislak
Global Regulatory Affairs Advocacy Manager, Roquette |
|
Vice Chair for User Relations
2025 / 2026 / 2027 |
Jennifer Putnam
Senior Supervisor AR&D, Perrigo |
|
Officer
2025 / 2026 |
Mike Cassell
cGMP Quality Assurance Manager |
|
Officer
2025 / 2026
|
Teresa Wegesser
Scientific Associate Director, Amgen
|
|
Officer
2026 / 2027 |
Nigel Langley
Global Technical Director, Life Sciences, gChem |
|
Officer
2026 / 2027 |
Candy Reynolds-Cummings
Regulatory and Product Stewardship Manager | Smart Effects | Americas Region EQR, Evonik
|